BACE1 and Alzheimer disease: Similarly, in the 3xTg‐AD model, which harbors mutations in APP, Psen1, and MAPT, ramalin improved cognitive function, significantly reduced hippocampal BACE1 levels, and decreased phosphorylation of tau at residues S202, T205, S396, and S404.